Download PDF
Thromb Haemost 2006; 96(02): 228-230
DOI: 10.1160/TH06-03-0144
Case Report
Schattauer GmbH

R924Q substitution encoded within exon 21 of the von Willebrand Factor gene related to mild bleeding phenotype

Patricia Casais   *
1   Departamento de Hemostasia y Trombosis, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina
,
Gonzalo A. Carballo   *
1   Departamento de Hemostasia y Trombosis, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina
,
Adriana I. Woods
2   Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Buenos Aires, Argentina
,
Ana C. Kempfer
2   Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Buenos Aires, Argentina
,
Cristina C. Farías
2   Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Buenos Aires, Argentina
,
Silvia H. Grosso
1   Departamento de Hemostasia y Trombosis, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina
,
María A. Lazzari
1   Departamento de Hemostasia y Trombosis, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina
2   Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), Buenos Aires, Argentina
› Author AffiliationsFinancial support: Grants from the René Barón Foundation, the National Research Council (CONICET) and the Science and Technology Secretary (SECYT) supported this investigation in part .
Further Information

Publication History

Received 09 March 2006

Accepted after minor revision 18 June 2006

Publication Date:
28 November 2017 (online)

    Permissions and Reprints

 

* Both authors contributed equally to this investigation.


 

  • References

  • 1 Werner EJ, Broxson EH, Tucker EL. et al. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123: 893-8.
    CrossrefPubMedGoogle Scholar
  • 2 Nichols WC, Ginsburg D. Reviews in molecular Medicine. Von Willebrand disease. Medicine 1997; 76: 1-19.
    CrossrefPubMedGoogle Scholar
  • 3 Nesbitt IM, Hampton KK, Preston FE. et al. A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations. Thromb Haemost 1999; 82: 1061-4.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 von Willebrand disease mutation database, International Society on Thrombosis and Haemostasis. http://www.sheffield.ac.uk/vwf/
    PubMedGoogle Scholar
  • 5 Hilbert L, D’ Oiron R, Fressinaud E. et al. INSERM Network on Molecular Abnormalities in von Willebrand Disease. First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene. J Thromb Haemost 2004; 02: 2271-3.
    CrossrefPubMedGoogle Scholar
  • 6 Schneppenheim R, Lenk H, Obser T. et al. Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization. Thromb Haemost 2004; 92: 36-41.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Jorieux S, Fressinaud E, Goudemand J. et al. Conformational changes in the D’ domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment. Blood 2000; 95: 3139-45.
    PubMedGoogle Scholar
  • 8 Allen S, Abuzenadah AM, Blagg JL. et al. Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor. Blood 2000; 95: 2000-7.
    PubMedGoogle Scholar
  • 9 Hilbert L, Jorieux S, Proulle V. et al. INSERM Network on Molecular Abnormalities in von Willebrand Disease. Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity. Br J Haematol 2003; 120: 627-32.
    CrossrefPubMedGoogle Scholar
  • 10 Taylor LD. The application of the biotin/avidin system to the von Willebrand factor antigen immunoassay. Thromb Haemost 1988; 59: 251-4.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Zacharsky LR, Rosenstein R. Standarization of the one stage assay for FVIII (antihemophilic factor). Am J Clin Pathol 1978; 70: 280-6.
    CrossrefPubMedGoogle Scholar
  • 12 Macfarlane DE, Stibbe J, Kirby EP. et al. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975; 34: 306-8.
    PubMedGoogle Scholar
  • 13 Casonato A, Pontara E, Zerbinati P. et al. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications. Am J Clin Pathol 1998; 109: 347-52.
    CrossrefPubMedGoogle Scholar
  • 14 Farías C, Kempfer AC, Blanco A. et al. Visualization of the multimeric structure of von Willebrand factor by immunoenzymatic stain using avidin-peroxidase complex instead of avidin-biotin peroxidase complex. Thromb Res 1989; 53: 513-8.
    CrossrefPubMedGoogle Scholar
  • 15 Bowen DJ, Standen GR, Mazurier C. et al. Type 2N von Willebrand disease: rapid genetic diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F) – detection of a novel candidate type 2N mutation: C2810T (R854W). Thromb Haemost 1998; 80: 32-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Ganguly A, Rock MJ, Prockop DJ. Conformation- Sensitive Gel Electrophoresis for rapid detection of single base differences in double-stranded PCR products and DNA fragments: evidences for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 1993; 90: 10325-9.
    CrossrefPubMedGoogle Scholar
  • 17 Goodeve A, Hashemi M, Castaman G. et al. Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD). J Thromb Haemost 2005; 03 S 1: OR281.
    PubMedGoogle Scholar
  • 18 Hashemi M, Peake I, Goodeve A. et al. The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project. J Thromb Haemost 2005; 03 S 1: P1469.
    PubMedGoogle Scholar
  • 19 Casonato A, Sartorello F, Cattini MG. et al. An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. Blood 2003; 101: 151-6.
    CrossrefPubMedGoogle Scholar
  • 20 Mazurier C, Gaucher C, Jorieux S. et al. Biological effect of desmopressin in eight patients with type 2N (‘Normandy’) von Willebrand disease. Collaborative Group. Br J Haematol 1994; 88: 849-54.
    CrossrefPubMedGoogle Scholar
  • 21 Federici AB, Mazurier C, Berntorp E. et al. Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study. Blood 2004; 103: 2032-8.
    CrossrefPubMedGoogle Scholar
  • 22 Lopez-Fernandez MF, Blanco-Lopez MJ, Castineira MP. et al. Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII. Am J Hematol 1992; 40: 20-7.
    CrossrefPubMedGoogle Scholar
  • 23 Lethagen S, Castaman G, Federici A. et al. Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD. J Thromb Haemost 2005; 03 S 1: H08.
    PubMedGoogle Scholar